Authors

Accelerating Personalization

How is AI solving pharma's speed-to-market challenge?

Navigating Access and Reimbursement Through Uncertainty

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Revolutionizing Patient Care: The Top Five Benefits of Investing in Innovation

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Pharma’s US Manufacturing Push Faces a Long Investment Horizon

In the final part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, explains that with plant buildouts and validation requiring three to five years, today’s reshoring momentum reflects near-term policy pressures, but global demand and overseas biosimilar growth will ultimately shape the industry’s next phase.

The Hidden Economics of Health Insurance Affordability

In the third part of his Pharma Commerce video interview, Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, points out that from employer-paid premiums to Medicare and Medicaid subsidies, the US system relies on layered financial support to keep coverage within reach—underscoring how few individuals can realistically pay the full cost of care or insurance on their own.

Keys to Advancing HCP Engagement

Why meaningful content must meet the right audience.

Caught Beneath the Surface: The Hidden Potential of Patient Data

Filling the gaps in the patient journey within an increasingly complex data environment.

Bridging People, Process, and Technology

How can 360° connectivity drive pharma innovation?

Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste

Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.

The Role of CDMOs in the Pharma Cold Chain Machine

Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.

The Unwritten Requirement for CNPVs

In the third part of his Pharma Commerce video interview, Brad Stewart, BDO’s national life sciences co-leader, explains that while the FDA has not defined the specific level of manufacturing commitment needed to improve US supply chain resilience, applicants for the voucher should focus on linking unique or rare disease therapies—particularly in areas like oncology—with domestic onshoring efforts to move their applications to the top of the pile for selection.

Sonicu serves scores of hospital-based, specialty and retail pharmacies with our simple and affordable temperature and environmental monitoring

Learn how easy and affordable it can be to adopt a wireless remote temperature and environmental monitoring system that can protect your vital temperature-sensitive assets while automating tedious compliance

Precision Dosing as a Market Strategy: How Model-Informed Tools Drive Cost, Speed and Access

By reducing waste, improving forecasting, and strengthening payer negotiations, these technologies are helping pharmaceutical companies unlock efficiency, accelerate adoption, and differentiate in competitive markets.

Beyond Awareness: Modeling Shared Decision-Making in Patient Communications

When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.

Serialization 2.0: Why It’s Time to Upgrade, and What’s at Stake

This serialization system represents a business imperative that yields significant competitive advantages.

Smart Packaging in Pharma: Driving Adherence and Safety Through Digital Innovation

These innovations are revolutionizing pharmaceutical packaging by enhancing drug safety, combating counterfeiting, ensuring regulatory compliance, and improving patient adherence across the supply chain.

Modernizing the Last Mile

In the final part of his Pharma Commerce video interview, Arthur Axelrad, co-founder and CEO of Dispatch Science, explains how outdated, batch-based communication between shippers and carriers is undermining last-mile resilience—and why APIs, cloud platforms, and real-time connectivity are essential to improving transparency, safety, and speed in healthcare logistics.

Why CX Is a Difference Maker for Pharma

Direct-to-consumer and direct-to-patient models are major contributors.

HDA 2025 Traceability Seminar: Closing Gaps in Pharma’s Supply Chain

Ullrich Mayeski, community engagement director of health with GS1 US, emphasizes the critical need to address interoperability challenges at the dispenser level, ranging from small independent pharmacies to large hospital systems.

Building Intelligent Pharma Supply Chain Management with Real-World Data

Approaches powered by RWD can clear the way for a greater focus on patient-centered care.

Serialization 2.0: Why It’s Time to Upgrade, and What’s at Stake

This serialization system represents a business imperative that yields significant competitive advantages.

Navigating the Landscape of Global AI Governance

The importance of embracing universal values and business models that prioritize humanity.

HTI-4 Standards Target Lack of Transparency in Medication Access

In the final part of his Pharma Commerce video interview, Colin Banas, MD, DrFirst’s chief medical officer, explains how amid soaring patient and provider frustration, new HTI-4 standards are rapidly forcing change across the insurance and technology sectors to solve the current "transparency problem," making the status of a life-saving prescription as clear and actionable as tracking a takeout order.

Community Pharmacies in Crisis: Navigating the Challenges and Closures

With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.

Navigating Access and Reimbursement Through Uncertainty

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

Working with the Middle

How pharma can productively coexist with PBMs—and still lower drug costs faster.

Why Your EHR Messaging Must Be Real-Time

This first-party approach to data-driven messaging can ensure timely, compliant, and personalized engagement with healthcare providers at the point of care.